Compound ID | 1832
DIS-73285
Synonym(s): DDS-03 series
Class: Electron transport chain inhibitor
| Details of activity: | Involves the electron transfer proteins (ETFs) A/B/D in N. gonorrhoeae |
| Description: | Selective activity against Neisseria spp. Very low MIC values |
| Institute where first reported: | Summit Therapeutics |
| Year first mentioned: | 2018 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive (as of 2022) |
| External links: | |
| Citation: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566547/ |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.